The Treatment of Antisocial Personality Disorder

被引:0
作者
Black D.W. [1 ]
机构
[1] Department of Psychiatry, University of Iowa Carver College of Medicine, 2-126b MEB/Psychiatry Research, Iowa City, 52242, IA
关键词
Antidepressants; Antipsychotics; Antisocial personality disorder; Cognitive-behavioral therapy; Mood stabilizers; Sociopathy;
D O I
10.1007/s40501-017-0123-z
中图分类号
学科分类号
摘要
Purpose of Review Antisocial personality disorder (ASPD) is defined by its pattern of socially irresponsible, exploitative, and guiltless behavior. The disorder is common and costly to society. ASPD starts in childhood or early adolescence when it is diagnosed as conduct disorder. If the symptoms persist past age 18, the diagnosis changes to ASPD. The disorder moderates with advancing age and many individuals will no longer meet criteria for the disorder as older adults. Recent Findings The treatment of ASPD is challenging and complicated by a dearth of research evidence. There are no medications approved by the US Food and Drug Administration for treatment of the disorder, nor are there proven psychological treatments. Medications can be prescribed to treat comorbid disorders (e.g., panic disorder, major depression), or “off-label” to target aggression and impulsivity associated with ASPD. Treatment models employing cognitive-behavioral therapy have been developed, and some reports suggest benefit. Summary Patients with ASPD should not routinely be treated with psychotropic medication. Medications may be helpful in treating comorbid psychiatric disorders such as major depression, or aggressive symptoms common in these patients. Cognitive-behavior therapy may be helpful for those with milder syndromes. © 2017, Springer International Publishing AG.
引用
收藏
页码:295 / 302
页数:7
相关论文
共 58 条
  • [1] North C.S., Yutzy S.H., Goodwin and Guze’s psychiatric diagnosis, (2010)
  • [2] Diagnostic and statistical manual of mental disorders, (2013)
  • [3] Black D.W., Bad boys, bad men—confronting antisocial personality disorder (sociopathy), revised and updated, (2013)
  • [4] Robins L., Helzer J.E., Weissman M.M., Et al., Lifetime prevalence of specific psychiatric disorders in three sites, Arch Gen Psychiatry, 41, pp. 949-958, (1984)
  • [5] Kessler R.C., McGonagle K.A., Zhao S., Lifetime and twelve month prevalence of DSM-III-R psychiatric disorders in the United States—results from the National Co-morbidity Survey, Arch Gen Psychiatry, 51, pp. 8-19, (1994)
  • [6] Compton W.M., Conway K.P., Stinson F.S., Et al., Prevalence, correlates, and comorbidity of DSM-IV antisocial personality syndromes and alcohol and specific drug use disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions, J Clin Psychiatry., 66, pp. 677-685, (2005)
  • [7] Robins L.N., The Epidemiology of Antisocial Personality Disorder in Psychiatry, 3, (1987)
  • [8] Black D.W., Gunter T., Loveless P., Et al., Antisocial personality disorder in incarcerated offenders: clinical characteristics, comorbidity, and quality of life, Ann Clin Psychiatry, 22, pp. 113-120, (2010)
  • [9] Hesselbrock V., Meyer R., Hesselbrock M., Psychopathology and addictive disorders: the specific case of antisocial personality disorder in addictive states, (1992)
  • [10] Guze S.B., Wolfgram E.D., McKinney J.K., Et al., Psychiatric illness in the families of convicted criminals: a study of 519 first degree relatives, Dis Nerv Sys, 28, pp. 651-659, (1967)